BAXANO SURGICAL, INC.
CIK:0001230355|SEC Filings
|
Condensed Consolidated Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
Jun. 30, 2013
|
|
| Revenue | $ 4,656 | $ 3,877 | $ 9,068 | $ 6,977 |
| Cost of revenue | 1,417 | 1,295 | 2,680 | 2,327 |
| Gross profit | 3,239 | 2,582 | 6,388 | 4,650 |
| Operating expenses: | ||||
| Research and development | 2,465 | 1,509 | 4,452 | 2,794 |
| Sales and marketing | 6,001 | 6,032 | 13,275 | 10,959 |
| General and administrative | 2,567 | 1,860 | 5,115 | 3,411 |
| Merger and integration expenses | 0 | 1,583 | 19 | 2,895 |
| Total operating expenses | 11,033 | 11,053 | 22,861 | 20,219 |
| Operating loss | (7,794) | (8,471) | (16,473) | (15,569) |
| Non-operating items: | ||||
| Interest expense | (759) | (73) | (1,135) | (73) |
| Change in fair value of derivative and warrant liabilities | 2,676 | 0 | 2,624 | 0 |
| Other income, net | 10 | 13 | 8 | 11 |
| Net loss | (5,867) | (8,531) | (14,976) | (15,631) |
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustments | (1) | 1 | (2) | 0 |
| Comprehensive loss | (5,868) | (8,530) | (14,978) | (15,631) |
| Net loss per common share - basic and diluted (in dollars Per Share) | $ (0.12) | $ (0.26) | $ (0.31) | $ (0.51) |
| Weighted average common shares outstanding - basic and diluted (in shares) | 48,520 | 33,408 | 47,793 | 30,379 |
|
US Treasury and Government [Member]
|
||||
| Operating expenses: | ||||
| Charges related to U.S. Government settlement | $ 0 | $ 69 | $ 0 | $ 160 |
|
Other Condensed Consolidated Balance Sheet Information
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2014
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Condensed Financial Information of Parent Company Only Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Condensed Financial Information of Parent Company Only Disclosure [Text Block] |
Information regarding other accounts on our condensed consolidated balance sheets is as follows (in thousands): Property and equipment, net
Accrued expenses
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||